Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Documents similaires

• Triple artemisinin-based combination therapies for malaria – a new paradigm?
  par: van der Pluijm, RW, et autres
  Publié: (2020)
• Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
  par: Peto, TJ, et autres
  Publié: (2022)
• Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
  par: Miotto, O, et autres
  Publié: (2020)
• Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
  par: Tindana, P, et autres
  Publié: (2021)
• Artemisinin and derivatives in the treatment of uncomplicated malaria.
  par: White, N, et autres
  Publié: (1998)